Personalized Diagnostic and Treating Techniques for Cerebral Glioma Based on Auxiliary Neuro-Imaging: A Multi-Center Clinical Research

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046375

Enrollment

Unknown

Registered

2021-05-15

Start date

2021-05-15

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Glioma

Interventions

Review training Group:Nil

Prospective observational Group I:Nil

Prospective observational Group II:NI

Prospective observational Group III:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years, male or female; 2. Initially diagnosed as cerebral glioma based on MRI (T2 flair, T1 enhanced, DTI, ADC, etc) and planned to undergo craniotomy for tumor resection had no surgical contraindications.

Exclusion criteria

Exclusion criteria: 1. To be admitted to the hospital for simple needle biopsy; 2. Patients with severe medical diseases who cannot tolerate surgery during the same period; 3. Those who have bleeding tendency or abnormal blood coagulation function, or have not stopped taking aspirin, clopidogrel and other anticoagulants for a long time; 4. Women during pregnancy and lactation; 5. Participants in other clinical trials during the same period.

Design outcomes

Primary

Measure	Time frame
Accuracy of diagnosis and prognosis;Prediction of tumor recurrence;	—

Countries

China

Contacts

Public ContactChen Liang

Huashan Hospital, Fudan University

chenlianghs@126.com+86 13661882460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026